The FDA granted marketing authorization—under the De Novo premarket review pathway—for the Bridge-Enhanced ACL Repair (BEAR) Implant, an anterior cruciate ligament (ACL) implant intended to serve as an alternative to ACL reconstruction to treat ACL tears.
Read more: FDA Authorizes Marketing of New Implant to Repair a Torn ACL